Drug class · Pain & inflammation
Opioid agonists Drug Codes & NDCs
Drugs that activate opioid receptors. Most are DEA-scheduled; the schedule is shown on each NDC record.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methadone Hydrocloride dye-free, sugar-free, unflavoredmethadone hydrochloride | Methadone hydrochloride 10 mg/mL | ConcentrateOral | Bryant Ranch Prepack | 72162-1085 |
| Methadosemethadone hydrochloride | Methadone hydrochloride 10 mg/mL | ConcentrateOral | SpecGx LLC | 0406-0527 |
| Methadose Dispersiblemethadone hydrochloride | Methadone hydrochloride 40 mg/1 | TabletOral | SpecGx LLC | 0406-0540 |
| Methadose Sugar-Freemethadone hydrochloride | Methadone hydrochloride 10 mg/mL | ConcentrateOral | SpecGx LLC | 0406-8725 |
| Mitigomorphine sulfate | Morphine sulfate 200 mg/20mL | InjectionEpidural, Intrathecal | Piramal Critical Care, Inc. | 66794-160 |
| Mitigomorphine sulfate | Morphine sulfate 500 mg/20mL | InjectionEpidural, Intrathecal | Piramal Critical Care, Inc. | 66794-162 |
| Morphine Sulfate | Morphine sulfate 15 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0235 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0236 |
| Morphine Sulfate | Morphine sulfate 10 mg/5mL | SolutionOral | Hikma Pharmaceuticals USA Inc. | 0054-0237 |
| Morphine Sulfate | Morphine sulfate 20 mg/5mL | SolutionOral | Hikma Pharmaceuticals USA Inc. | 0054-0238 |
| Morphine Sulfate | Morphine sulfate 100 mg/5mL | SolutionOral | Hikma Pharmaceuticals USA Inc. | 0054-0517 |
| Morphine Sulfate | Morphine sulfate 20 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1277 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1278 |
| Morphine Sulfate | Morphine sulfate 50 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1279 |
| Morphine Sulfate | Morphine sulfate 60 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1280 |
| Morphine Sulfate | Morphine sulfate 80 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1281 |
| Morphine Sulfate | Morphine sulfate 100 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1282 |
| Morphine Sulfate | Morphine sulfate 40 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1479 |
| Morphine Sulfate | Morphine sulfate 10 mg/5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-0904 |
| Morphine Sulfate | Morphine sulfate 10 mg/5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-4955 |
| Morphine sulfate | Morphine sulfate 30 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 0228-3090 |
| Morphine sulfate | Morphine sulfate 60 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 0228-3091 |
| Morphine sulfate | Morphine sulfate 90 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 0228-3092 |
| Morphine sulfate | Morphine sulfate 120 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 0228-3093 |
| Morphine sulfate | Morphine sulfate 45 mg/1 | Capsule, Extended releaseOral | Actavis Pharma, Inc. | 0228-3116 |